Our November webinars (with Q&A) explain the indicators, address CBD policymakers' concerns, and describe how they are being deployed in Japan, Australia, Colombia, Mexico, France, Sweden, Belgium, and South Africa. We show that indicators are relevant, feasible, connected to the GBF, peer-reviewed, and ready for use (criteria outlined in CBD/WG2020/3/3/Add.1)